July 28, 2021
Article
A recent study of sexually active young women in Africa found that initiation of HIV preexposure prophylaxis (PrEP) was high at 95% and one-fifth showed high adherence at 6 months.
July 25, 2021
With millions of Americans affected by sexually transmitted infections (STI) an emphasis on prevention and control strategies was included in the recommendations.
July 22, 2021
Investigators wanted to study usage of F/TAF vs F/TDF in clinical practice and HIV seroconversion.
July 21, 2021
Adherence for daily dosing decreased and event-driven PrEP usage increased in a Chinese study.
In a pilot project, customers were surveyed about HIV risk behaviors to gain further insights and assessed for potential PrEP utilization.
July 20, 2021
A meta-analysis study found that 70% of PrEP users either stopped or had inadequate adherence within 6 months of initiation.
July 19, 2021
Small survey from gay and bisexual men (GBM) inquired about their experiences during COVID-19 restrictions, and feedback on PrEP.
In Brazil, a concerted effort of recruiting adolescents was made to go out and talk with them about PrEP.
US residents with HIV have higher rates of mortality than their peers without infection, but the gap is narrowing, a recent study showed.
July 18, 2021
Video
Investigators surveyed men who have sex with men (MSM) about long-acting injectable pre-exposure prophylaxis (PrEP) including attitudes towards potentially taking it and barriers to usage.
